A randomized controlled trial from two hospitals in Denmark published in the British Medical Journal set out to assess the effect of a group exercise intervention, as an adjunct to conventional care, on fatigue, physical capacity, general wellbeing, physical activity, and quality of life in patients with cancer who were undergoing chemotherapy. They found an improvement in physical capacity, but no significant effect was seen on global health status or quality of life. They concluded that a supervised multimodal exercise intervention including high and low intensity components was feasible and could safely be used in patients with various cancers who were receiving adjuvant chemotherapy or treatment for advanced disease. The intervention reduced fatigue and improved vitality, aerobic capacity, muscular strength, and physical and functional activity, and emotional wellbeing, but not quality of life.
ÂÂ
Related posts:
